RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C808. A total of 15 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $134,000 | – | 41,648 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Intellectus Partners, LLC | 8,000 | $9,000 | 0.00% |
| SG Americas Securities, LLC | 163,730 | $192,000 | 0.00% |
| Advisor Group, Inc. | 19 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 548 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 5,718 | $7,000 | 0.00% |
| BlackRock Inc. | 1,115 | $1,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,806 | $16,000 | 0.00% |
| HighTower Advisors, LLC | 10,000 | $12,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 355 | $0 | 0.00% |